New York University Medical Center PRIME — New York, New York

New York University Medical Center PRIME is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

New York University Medical Center PRIME has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia.

Sponsors: Biogen, Takeda, Eisai Inc..

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Medical Center PRIME?

New York University Medical Center PRIME has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Medical Center PRIME conducted?

New York University Medical Center PRIME has 9 clinical trials on record, with 3 currently active. Their work covers Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia.

Is New York University Medical Center PRIME accredited by Crixeo Health?

New York University Medical Center PRIME has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York University Medical Center PRIME?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.